BIO Supports NAS Findings

  • Contact: Peper Long
    (202) 962-9200
  • Recommend
  • Tweet
  • Print
  • Email

WASHINGTON, D.C. - (January 18, 2002) - Biotechnology Industry Organization Vice President for Bioethics Michael Werner released the following statement on the National Academy of Science’s human reproductive cloning report:

“BIO supports a legally enforceable ban on the practice of human reproductive cloning, according to definitions and findings included in today’s report from the National Academy of Sciences Committee on Science, Engineering and Public Policy. The potential practice of human reproductive cloning is dangerous and fraught with ethical concerns.

“However, it is critical to note that the Academy limited its recommendation for a ban to human reproductive cloning. BIO agrees that research using nuclear transplantation technology, especially as applied to stem cell research, should continue, as the research has the potential to provide new therapies and cures for millions of Americans suffering from devastating conditions including Parkinson’s and Alzheimer’s disease, diabetes, various cancers and spinal cord injuries.

“Also noted in the Academy report, nuclear transplantation does not
necessarily involve implantation of an embryo and thus, does not result in a complete, live born human.

“BIO respects the Academy’s thoughtful process, and we also recognize that the speed of scientific research must be tempered by appropriate and thorough public debate.”

BIO represents more than 1,000 biotechnology companies, academic
institutions, state biotechnology centers and related organizations in all 50 states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products.

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.